Chorea as the initial manifestation of essential thrombocytosis

Authors

  • Miguel Solé Sabater Servicio de Neurología, Hospital Universitario Nuestra Señora de Candelaria. Universidad de La Laguna, Santa Cruz de Tenerife, España https://orcid.org/0000-0003-3677-4262
  • Diego García Silvera Servicio de Medicina Interna, Hospital Universitario Nuestra Señora de Candelaria, Santa Cruz de Tenerife, España
  • Carlos Enrique Solé Violán Servicio de Neurología. Unidad de Esclerosis Múltiple. Hospital Universitario Nuestra Señora de Candelaria, Santa Cruz de Tenerife, España https://orcid.org/0000-0002-8029-359X
  • Mario Ríos de Paz Servicio de Hematología y Hematoterapia, Unidad de Coagulación, Hospital Universitario Nuestra Señora de Candelaria, Santa Cruz de Tenerife, España

DOI:

https://doi.org/10.32818/reccmi.a6n2a9

Keywords:

Chorea, JAK-2-V617F, movement disorders, myeloproliferative disorders, neurology, thrombocytosis.

Abstract

Introduction: Chorea is an extrapyramidal hyperkinetic syndrome. Differential diagnosis is very wide and includes hereditaries and acquired disorders. Clinical case: We present the case of a 68-year-old man at the Emergency Department with orolingual, cervical and limbs movements, not stereotyped or voluntaries. We excluded main causes of chorea. However, we discover a persistent thrombocytosis in previous hemograms. Genetic tests will demonstrate a JAK-2-V617F mutation. Conclusions: Myeloproliferative disorders are a few known causes of chorea. Clinic course is usually favourable if the hematologic condition is treated.

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...

References

Daroff RB, Jankovic J, Mazziotta JC, Pomeroy SL. Bradley’s neurology in clinical practice. 7th edition. Elsevier. 2016.

Hermann A, Walker RH. Diagnosis and treatment of chorea syndromes. Curr Neurol Neurosci Rep. 2015; 15(2): 514. doi: https://doi.org/10.1007/s11910-014-0514-0.

Pringsheim T, Wiltshire K, Day L, Dykeman J, Steeves T, Jette N. The incidence and prevalence of Huntington's disease: a systematic review and meta-analysis. Mov Disord. 2012; 27(9): 1083-91. doi: https://doi.org/10.1002/mds.25075.

Díaz-Grez F, Lay-Son L, del Barrio-Guerrero E, Vidal-González P. Corea de Sydenham. Análisis clinico de 55 pacientes con seguimiento prolongado [Sydenham's chorea. A clinical analysis of 55 patients with a prolonged follow-up]. Rev Neurol. 2004; 39(9): 810-5.

Ashenhurst EM. Chorea complicating polycythemia rubra vera. Can Med Assoc J. 1972; 107(5): 434 passim.

Marvi MM, Lew MF. Polycythemia and chorea. Handb Clin Neurol. 2011; 100: 271-6. doi: https://doi.org/10.1016/B978-0-444-52014-2.00019-7.

Venkatesan EP, Ramadoss K, Balakrishnan R, Prakash B. Essential thrombocythemia: Rare cause of chorea. Ann Indian Acad Neurol. 2014; 17(1): 106-7. doi: https://doi.org/10.4103/0972-2327.128569.

Barbui T, Thiele J, Gisslinger H, Kvasnicka HM, Vannucchi AM, Guglielmelli P et al. The 2016 WHO classification and diagnostic criteria for myeloproliferative neoplasms: document summary and in-depth discussion. Blood Cancer J. 2018; 8(2): 15. doi: https://doi.org/10.1038/s41408-018-0054-y.

Published

2021-08-31

How to Cite

1.
Solé Sabater M, García Silvera D, Solé Violán CE, Ríos de Paz M. Chorea as the initial manifestation of essential thrombocytosis. Rev Esp Casos Clin Med Intern [Internet]. 2021 Aug. 31 [cited 2024 Dec. 4];6(2):24-6. Available from: https://www.reccmi.com/RECCMI/article/view/652